Clinical Trial Update: A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating Cosopt as first-line therapy for glaucoma and ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Cosopt (dorzolamide/timolol)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED